Table 2.
Pathogen | Vaccine Tradename | Route of Administration | Adjuvant | Manufacturer |
---|---|---|---|---|
Adenovirus Type 4 and 7 Vaccine * | - | Oral | - | Barr Labs, Inc. Montvale, NJ, USA |
Measles, Mumps, and Rubella Virus Vaccine | M-M-R® II | Subcutaneous | - | Merck & Co., Inc. Kenilworth, NJ, USA |
Tuberculosis (Bacillus of Calmette and Guerin (BCG)) Vaccine |
BCG Vaccine | Percutaneous | - | Organon Teknika Corp., LLC. Durham, NC, USA |
Cholera Vaccine | Vaxchora® | Oral | - | Emergent Travel Health, Inc. Gaithersburg, MD, USA |
Dengue Tetravalent Vaccine | DENGVAXIA® | Subcutaneous | - | Sanofi Pasteur Inc. Lyon, France |
Ebola Zaire Vaccine | ERVEBO® | Intramuscular | - | Merck & Co., Inc. Kenilworth, NJ, USA |
Influenza Vaccine | FluMist® | Intranasal | - | Medimmune, LLC. Gaithersburg, MD, USA |
Rotavirus Vaccine | Rotarix® | Oral | - | GlaxoSmithKline Biologicals, Brentford, UK |
Varicella Virus Vaccine | VARIVAX® | Subcutaneous | - | Merck & Co., Inc. Kenilworth, NJ, USA |
Smallpox (Vaccinia) Vaccine | ACAM2000® | Percutaneous | - | Sanofi Pasteur Biologics Co. Cambridge, MA, USA |
* Approved for use in military populations 17 through 50 years of age.